Silence Therapeutics (SLN) Shares Issued (2020 - 2025)

Silence Therapeutics' Shares Issued history runs 6 years deep, the most recent figure standing at $1000.0 for Q2 2025.

• In Q2 2025, Shares Issued fell 99.92% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $1000.0 (down 99.99% YoY), while the FY2025 annual figure was $15000.0, down 99.99% from the prior year.
• Shares Issued came in at $1000.0 for Q2 2025 at Silence Therapeutics, down from $14000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $133.0 million in Q1 2024 to a low of -$98000.0 in Q4 2024.
• A 5-year average of $16.7 million and a median of $904000.2 in 2021 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued jumped 193727.9% in 2022 and tumbled 100.79% in 2024, its largest moves.
• Silence Therapeutics' Shares Issued stood at $1348.0 in 2021, then jumped by 10515.44% to $143097.3 in 2022, then jumped by 8541.39% to $12.4 million in 2023, then sank by 100.79% to -$98000.0 in 2024, then surged by 101.02% to $1000.0 in 2025.
• According to Business Quant data, Shares Issued over the past three periods registered $1000.0, $14000.0, and -$98000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison